Can Ketamine Make PTSD Worse? What Research Shows

Ketamine can make PTSD worse in some people, though the overall research picture is mixed. A systematized review of six studies on ketamine and PTSD found that one in six showed increased incidence or severity of symptoms, two showed decreased symptoms, and the remaining three found no relationship at all. That uneven track record, combined with specific psychological risks during and after treatment, means the answer depends heavily on individual factors and how the drug is administered.

What the Research Actually Shows

The American Psychological Association’s latest treatment guidelines do not recommend ketamine for PTSD. The evidence base is considered insufficient to recommend for or against it. Many existing studies are small, at risk of bias, or use unclear treatment protocols. The strongest evidence for treating PTSD still points to cognitive processing therapy, prolonged exposure therapy, and trauma-focused cognitive behavioral therapy.

That said, ketamine isn’t categorically harmful for PTSD either. Some case reports and small studies show rapid, meaningful symptom relief. The problem is that benefits tend to be short-lived. Clinical improvements typically last one to two weeks before patients return to their baseline. In one reported case, a patient experienced complete reduction in anxiety and depression for 14 days, then relapsed into a similar state within 24 hours. Another patient improved for 15 days before returning to baseline. This pattern of rapid relief followed by a return of symptoms can feel like a crash, and for someone with PTSD, that emotional whiplash itself can be destabilizing.

How Ketamine Can Trigger Flashbacks

Ketamine is a dissociative drug, and dissociation sits at the heart of many PTSD symptoms. During treatment, patients can experience vivid hallucinations, distorted perceptions of time and space, and a sense of detachment from their body. For someone with trauma history, these altered states can directly trigger flashbacks.

In one documented case, a 58-year-old man with a military background was sedated with ketamine for a shoulder procedure. He experienced severe agitation that resembled a PTSD flashback of past war scenes, requiring physical restraint and additional medication to control. This type of reaction, sometimes called emergence phenomena, happens as the drug’s effects shift or wear off, and it can be indistinguishable from a trauma re-experiencing episode. For people who have never processed certain traumatic memories, ketamine’s ability to unlock intense sensory and emotional experiences can surface material they aren’t prepared to handle.

The Brain Chemistry Behind Worsening Symptoms

Ketamine works by blocking certain receptors in the brain, which triggers a surge of glutamate, the brain’s primary excitatory chemical messenger. This surge is thought to be responsible for both the drug’s therapeutic potential and its most troubling side effects. The flood of neural activity in the prefrontal cortex can produce psychosis-like symptoms: paranoia, perceptual distortions, disorganized thinking, and heightened anxiety.

For someone with PTSD, whose nervous system is already stuck in a state of hyperarousal, that burst of excitatory brain activity can temporarily amplify the very symptoms they’re trying to treat. The racing heart, the feeling of being on edge, the sense that something terrible is about to happen: ketamine’s acute effects can mimic or intensify all of these. A meta-analysis published in JAMA Network Open confirmed that ketamine is associated with psychosis-like symptoms even in healthy volunteers, and recommended that bolus (rapid, all-at-once) administration be avoided in therapeutic settings to minimize these risks.

Timing Matters: Ketamine Near the Trauma

The risk appears to be higher when ketamine is given close to the time of a traumatic event. A review found that in two out of three studies examining ketamine and acute stress disorder (the condition that can develop in the days and weeks immediately after trauma), ketamine was associated with worsened symptoms. This is a notable finding because acute stress disorder often precedes PTSD. If ketamine disrupts the brain’s early processing of a traumatic event, possibly by intensifying dissociation during a critical window, it could set the stage for more entrenched PTSD symptoms later.

The distinction between using ketamine shortly after a trauma versus using it months or years later for established PTSD is important. The acute-phase risk appears more consistent in the research than the chronic-phase risk, though both carry unknowns.

When Ketamine Is Combined With Therapy

One approach that shows more promise than ketamine alone is ketamine-assisted psychotherapy, where drug sessions are paired with structured therapy visits. A large retrospective study found that this combination produced sustained reductions in anxiety, depression, and PTSD symptoms lasting up to five months after the last session. The protocol typically involves four to six guided ketamine sessions with dedicated psychotherapy integration visits woven between doses.

The integration component appears to be key. Without professional support to help process what comes up during a ketamine experience, patients are left to make sense of potentially overwhelming emotional material on their own. That unsupported processing is where the risk of worsening likely concentrates. A ketamine session can crack open emotional content that, without skilled guidance, becomes retraumatizing rather than healing.

Factors That Increase Your Risk

Several characteristics may make a person more vulnerable to negative outcomes with ketamine:

  • History of severe dissociation. If your PTSD already involves feeling detached from your body, losing time, or experiencing derealization, adding a dissociative drug introduces unpredictable interactions with symptoms you’re already struggling to manage.
  • Recent trauma. The research consistently shows more concerning results when ketamine is used close to the traumatic event rather than for long-established PTSD.
  • Lack of therapeutic support. Receiving ketamine infusions without accompanying psychotherapy removes the safety net that helps prevent symptom escalation.
  • How the drug is given. Rapid bolus administration carries higher risk of psychosis-like side effects than slow infusions delivered over 40 minutes.

The Rebound Problem

Even when ketamine provides genuine relief, the short duration of that relief creates its own risk. Feeling dramatically better for one to two weeks, then sliding back to where you started, is psychologically costly. For people with PTSD who already struggle with hopelessness, the cycle of relief and relapse can reinforce the belief that nothing works. Some patients describe the return of symptoms as feeling worse than baseline, not because their PTSD has objectively worsened, but because the contrast with the relief period makes the return more painful.

This is different from the drug chemically worsening PTSD, but the practical effect on a person’s mental state can be similar. Repeated cycles of hope and disappointment carry real psychological weight, particularly for people whose trauma already involves experiences of loss or abandonment.